Nov 10 (Reuters) - Johnson & Johnson's unit Janssen L.P. said on Friday it chose "Invega" as the brand name for its schizophrenia drug paliperidone extended-release. The U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback